A citation-based method for searching scientific literature

J J Meier, B Gallwitz, N Siepmann, J J Holst, C F Deacon, W E Schmidt, M A Nauck. Diabetologia 2003
Times Cited: 221







List of shared articles



Times cited

Peptides in the regulation of glucagon secretion.
Daniel B Andersen, Jens J Holst. Peptides 2022
3

Glucagon's Metabolic Action in Health and Disease.
Anja Zeigerer, Revathi Sekar, Maximilian Kleinert, Shelly Nason, Kirk M Habegger, Timo D Müller. Compr Physiol 2021
3

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Andreas F H Pfeiffer. Diabetes Obes Metab 2021
14

Incretins in obesity and diabetes.
Chee W Chia, Josephine M Egan. Ann N Y Acad Sci 2020
31

The role of GIP in α-cells and glucagon secretion.
Kimberley El, Jonathan E Campbell. Peptides 2020
15

Gut Peptide Agonism in the Treatment of Obesity and Diabetes.
Gerald Grandl, Aaron Novikoff, Richard DiMarchi, Matthias H Tschöp, Timo D Müller. Compr Physiol 2019
2

Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.
T D Müller, C Clemmensen, B Finan, R D DiMarchi, M H Tschöp. Pharmacol Rev 2018
78

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Tamer Coskun, Kyle W Sloop, Corina Loghin, Jorge Alsina-Fernandez, Shweta Urva, Krister B Bokvist, Xuewei Cui, Daniel A Briere, Over Cabrera, William C Roell,[...]. Mol Metab 2018
172

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models.
Elizabeth A Killion, Jinghong Wang, Junming Yie, Stone D-H Shi, Darren Bates, Xiaoshan Min, Renee Komorowski, Todd Hager, Liying Deng, Larissa Atangan,[...]. Sci Transl Med 2018
84

The New Biology and Pharmacology of Glucagon.
T D Müller, B Finan, C Clemmensen, R D DiMarchi, M H Tschöp. Physiol Rev 2017
135


The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?
Ricardo Godinho, Cristina Mega, Edite Teixeira-de-Lemos, Eugénia Carvalho, Frederico Teixeira, Rosa Fernandes, Flávio Reis. J Diabetes Res 2015
40

Glucagon and type 2 diabetes: the return of the alpha cell.
Asger Lund, Jonatan I Bagger, Mikkel Christensen, Filip K Knop, Tina Vilsbøll. Curr Diab Rep 2014
70